Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
20
self-reported 11–50 band
Founded
2013
13 years
Legal entities
1
ACRA
Office countries
3
3 addresses
Funding rounds
3
Series unknown · Oct 2022 · US$ 6.8M
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
ACM BIOLABS PTE. LTD.Entity record →
UEN201317235H
Legal entities
Show as table · ACM Biolabs: 1 registry entity
| ACM BIOLABS PTE. LTD. | UEN 201317235H |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
ACM Biolabs
- Innovative medicines through next generation targeted delivery.
- Versatile platform for infectious disease prevention and therapies.
We are based in two world leading innovation hubs for biotechnology: Singapore and Switzerland. Embedded in a rich ecosystem of pharmaceutical companies, biotechs, and institutional and private investors, we believe this is a valuable success factor to advance our science and pipeline programs. Our experienced team with senior ex-pharma veterans provide a basis to attract talent, partners and investors.
As a dedicated team combining pharmaceutical industry, biotech, and academic excellence we develop prophylactic treatment and therapeutic vaccines for infectious diseases and therapeutic vaccines for personalized cancer treatment based on our proprietary polymer based delivery platform technology.
We believe in challenging the status quo of targeted delivery in medicines and we are revolutionizing the new medicines with ACM platform. We develop these transformative medicines to treat or prevent diseases in a safe and well tolerable way.
_____ 1.
Our delivery is targeted to antigen-presenting cells. These dendritic cells are best suited to educate the immune system in an elegant way against virus antigens. Therefore, only low amounts of payloads in ACMs are needed.
2.
ACM delivery are only made of a few components, self-assemble and encapsulate proteins, peptides, and mRNA. That means an easy manufacturing process for vast amounts of bulk product.
3.
Our payload is protected at refrigerator temperatures. We can store mRNA at 4°C making storage and transport much easier.
Specialties
All 7 specialties
- Biotechnology
- Nanotechnology
- Vaccines
- Therapeutics
- Targeted Delivery
- Intranasal Vaccines
- Flexible payload
Locations
3
Countries with an office address3 addresses on record
Country footprint
Show as table · Offices in 3 countries
| Countries | 3 |
|---|---|
| Primary country | SG |
All codes: SG AU CH
Addresses
- CHAeschenplatz 6; Basel, BS 4052
- AU139 Macquarie Street; Sydney , NSW 2000
- SG71 Nanyang Dr; Singapore, Singapore 638075Primary
Grid intelligence Members
Funding
Rounds3
Round typeSeries unknown · venture round
Amount (USD)6,800,000
Stage ranknot recorded
Investors named1
Since last round3 yr 3 mo
Funding
Show as table · 3 funding rounds
| Rounds | 3 |
|---|---|
| Axis | 2013 to 2026 |
| Series unknown · 22 Oct 2022 | US$ 6.8M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under ACM Biolabs?
One Singapore entity on ACRA: ACM BIOLABS PTE. LTD. (UEN 201317235H), high confidence.
How many people work at ACM Biolabs?
20 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does ACM Biolabs have offices?
Three addresses on record across 3 countries. Primary: 71 Nanyang Dr, Singapore 638075.
Has ACM Biolabs raised funding?
Three rounds. Latest 22 October 2022: Series unknown, US$6,800,000, investor Ritz Venture Capital.
What does ACM Biolabs list as its specialties?
Seven tags on the brand's own list, among them biotechnology, nanotechnology and vaccines.
Which companies are listed alongside ACM Biolabs?
5 profiles list ACM Biolabs as a peer — 62nd percentile in Biotechnology Research. It lists ten peers of its own. AUM Biosciences and DotBio list it back.